{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:43:03Z","timestamp":1776177783065,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["NMUB20250003"],"award-info":[{"award-number":["NMUB20250003"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017527","name":"Jiangsu Cancer Hospital","doi-asserted-by":"publisher","award":["ZJ202204"],"award-info":[{"award-number":["ZJ202204"]}],"id":[{"id":"10.13039\/501100017527","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874058"],"award-info":[{"award-number":["81874058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151711","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:37:32Z","timestamp":1774658252000},"page":"151711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deciphering 14-3-3\u03b2-mediated phosphorylated alterations of cancer-related proteome in cisplatin resistance of gastric cancer"],"prefix":"10.1016","volume":"358","author":[{"given":"Ming","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151711_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","article-title":"The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis","volume":"18","author":"Chen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0015","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04025","article-title":"Burdens of stomach and esophageal cancer from 1990 to 2019 and projection to 2030 in China: findings from the 2019 Global Burden of Disease Study","volume":"14","author":"Jiang","year":"2024","journal-title":"J. Glob. Health"},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2026.151711_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","article-title":"Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer","volume":"86","author":"Zeng","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919877726","article-title":"First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis","volume":"11","author":"Cheng","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116310","article-title":"Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives","volume":"173","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1574892816666210929165729","article-title":"Current advances and outlook in gastric Cancer Chemoresistance: a review","volume":"17","author":"Zhang","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151711_bb0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2021.01.001","article-title":"14-3-3 proteins: novel pharmacological targets in neurodegenerative diseases","volume":"42","author":"Pair","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102572","article-title":"14-3-3 protein and its isoforms: a common diagnostic marker for Alzheimer\u2019s disease, Parkinson\u2019s disease and glaucomatous neurodegeneration","volume":"102","author":"Panda","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151711_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30624","article-title":"14-3-3 family of proteins: biological implications, molecular interactions, and potential intervention in Cancer, virus and neurodegeneration disorders","volume":"125","author":"Low","year":"2024","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151711_bb0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10565-021-09607-y","article-title":"27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming","volume":"38","author":"Jin","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13046-018-1005-y","article-title":"Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3\u03b7\/NF-\u03baB feedback loop","volume":"37","author":"Qiu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0065","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2024e13985","article-title":"PMEPA1 promotes gastric cancer cell proliferation by regulating the ubiquitin-mediated degradation of 14-3-3sigma and promoting cell cycle progression","volume":"57","author":"Huang","year":"2024","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151711_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.35176","article-title":"14-3-3sigma restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer","volume":"156","author":"Lonare","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.151711_bb0075","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1038\/s41388-021-01980-6","article-title":"Deregulated 14-3-3zeta and methionine adenosyltransferase alpha1 interplay promotes liver cancer tumorigenesis in mice and humans","volume":"40","author":"Lu","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151711_bb0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI120279","article-title":"Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B","volume":"129","author":"Zhou","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-018-1259-5","article-title":"Midostaurin potentiates rituximab antitumor activity in Burkitt\u2019s lymphoma by inducing apoptosis","volume":"10","author":"Ge","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151711_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"Database issue","key":"10.1016\/j.ijbiomac.2026.151711_bb0095","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151711_bb0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.151711_bb0105","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1128\/MCB.00265-08","article-title":"Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias","volume":"28","author":"Kurokawa","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151711_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151711_bb0115","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","article-title":"A review on caspases: key regulators of biological activities and apoptosis","volume":"60","author":"Sahoo","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151711_bb0120","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100770","article-title":"Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function","volume":"57","author":"Gao","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101980","article-title":"Challenges in the treatment of gastric cancer in the older patient","volume":"85","author":"Joharatnam-Hogan","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151711_bb0140","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.7150\/ijbs.113709","article-title":"Harnessing natural products to surmount drug resistance in gastric Cancer: mechanisms and therapeutic perspectives","volume":"21","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101097","article-title":"Pathological implication of protein post-translational modifications in cancer","volume":"86","author":"Pan","year":"2022","journal-title":"Mol. Aspects Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151711_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.apsb.2020.09.007","article-title":"Phosphorylation regulates cullin-based ubiquitination in tumorigenesis","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151711_bb0155","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1021\/acs.jmedchem.4c01936","article-title":"Recent developments in 14-3-3 stabilizers for regulating protein-protein interactions: an update","volume":"68","author":"Tian","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41413-024-00370-4","article-title":"Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases","volume":"12","author":"Zhou","year":"2024","journal-title":"Bone Res."},{"issue":"32","key":"10.1016\/j.ijbiomac.2026.151711_bb0165","doi-asserted-by":"crossref","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","article-title":"Mitochondria-targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116095","article-title":"Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-kappaB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance","volume":"266","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151711_bb0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jhep.2016.05.017","article-title":"14-3-3\u03b7 is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma","volume":"65","author":"Shen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0180","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003851","article-title":"A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3eta-modified tumor-associated proteome","author":"Jin","year":"2025","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41420-020-00330-x","article-title":"Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3epsilon-mediated survival mechanism","volume":"6","author":"Jin","year":"2020","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151711_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108416","article-title":"Dynamic interactions of dimeric hub proteins underlie their diverse functions and structures: a comparative analysis of 14-3-3 and LC8","volume":"301","author":"Howe","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yjmcc.2025.07.012","article-title":"14-3-3\/HIP-55 complex attenuates cardiomyocyte apoptosis","volume":"206","author":"Jiang","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151711_bb0200","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144016","article-title":"TNFR2\/14-3-3epsilon signaling complex instructs macrophage plasticity in inflammation and autoimmunity","volume":"131","author":"Fu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151711_bb0205","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.7150\/thno.92676","article-title":"Chronic stress dysregulates the hippo\/YAP\/14-3-3eta pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/0929867324666170426095015","article-title":"Structure, function, involvement in diseases and targeting of 14-3-3 proteins: an update","volume":"25","author":"Cau","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151711_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101043","article-title":"Proteomic analysis of Hsp90beta-selective inhibitors against triple-negative breast Cancer to gain a mechanistic insight","volume":"24","author":"Reynolds","year":"2025","journal-title":"Mol. Cell. Proteomics"},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151711_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207500","article-title":"Sequenced combinations of cisplatin and selected phytochemicals towards overcoming drug resistance in ovarian tumour models","volume":"21","author":"Althurwi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151711_bb0225","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/15384101.2022.2051971","article-title":"LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13","volume":"21","author":"Zhou","year":"2022","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151711_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41419-023-05629-y","article-title":"FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP","volume":"14","author":"Tufano","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.620907","article-title":"Heat shock protein 90 triggers multi-drug resistance of ovarian Cancer via AKT\/GSK3\u03b2\/\u03b2-catenin signaling","volume":"11","author":"Yin","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151711_bb0240","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1172\/JCI125963","article-title":"Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation","volume":"129","author":"Pan","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151711_bb0245","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1038\/s41467-022-35143-2","article-title":"HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation","volume":"13","author":"Oberoi","year":"2022","journal-title":"Nat. Commun."},{"issue":"49","key":"10.1016\/j.ijbiomac.2026.151711_bb0250","doi-asserted-by":"crossref","first-page":"15510","DOI":"10.1021\/bi048736m","article-title":"Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex","volume":"43","author":"Ogiso","year":"2004","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151711_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071701","article-title":"Phosphorylation in the charged linker modulates interactions and secretion of Hsp90\u03b2","volume":"10","author":"Weidenauer","year":"2021","journal-title":"Cells"},{"issue":"27","key":"10.1016\/j.ijbiomac.2026.151711_bb0260","doi-asserted-by":"crossref","first-page":"17029","DOI":"10.1074\/jbc.M114.624106","article-title":"Casein kinase 2 (CK2)-mediated phosphorylation of Hsp90beta as a novel mechanism of rifampin-induced MDR1 expression","volume":"290","author":"Kim","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151711_bb0265","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.0903392106","article-title":"Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models","volume":"106","author":"Caldas-Lopes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116562","article-title":"Small molecule inhibitors targeting heat shock protein 90: an updated review","volume":"275","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2026.151711_bb0275","article-title":"17-AAG promotes the degradation of HSP90 client METTL3 to suppress MYC RNA m(6)a modification and expression in colorectal cancer","volume":"337","author":"Meng","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151711_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100567","article-title":"Proteomics profiling reveals the molecular signatures and potential therapeutic targets of human nasopharyngeal carcinoma","volume":"22","author":"Fu","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108782","article-title":"Recent advances in HSP90 inhibitors as targeted cancer therapy: chemical scaffolds, isoform selectivity, and clinical progress","volume":"163","author":"Goel","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151711_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118195","article-title":"HSP90 inhibitors in cancer immunotherapy: therapeutic opportunities and challenges","volume":"301","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026016375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026016375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:45:34Z","timestamp":1776174334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026016375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S0141813026016375"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151711","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering 14-3-3\u03b2-mediated phosphorylated alterations of cancer-related proteome in cisplatin resistance of gastric cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151711"}}